Ethylene

Ethylene

SCHEMBL812649

C=C.O=C(CS)OCCOC(=O)CS

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
HSD17B10 Q99714 2/20 0.46
DGKA P23743 1/20 0.36
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
HIF1A Q16665 2/20 0.33
ADRA2A P08913 1/20 0.33
ADRA1A P35348 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
NAAA Q02083 1/20 0.31
CYP2C19 P33261 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL59459 0.94 TSHR (0.50) TSHRHSD17B10DGKAALDH1A1TP53
SCHEMBL10898409 0.91 TSHR (0.48) TSHRHSD17B10DGKAADRA2AADRA1A
SCHEMBL11224122 0.91 TSHR (0.48) TSHRHSD17B10DGKAADRA2AADRA1A
SCHEMBL11357980 0.86 TSHR (0.43) TSHRHSD17B10DGKAALDH1A1ADRA2A
SCHEMBL13864201 0.86 TSHR (0.43) TSHRHSD17B10DGKAALDH1A1TP53
Cyclohexane SCHEMBL8420400 0.86 TSHR (0.43) TSHRHSD17B10DGKAALDH1A1ADRA2A
SCHEMBL98638 0.86 TSHR (0.43) TSHRHSD17B10DGKAALDH1A1TP53
Ethylene Glycol SCHEMBL1468277 0.86 TSHR (0.43) TSHRHSD17B10DGKAADRA2AADRA1A
SCHEMBL97649 0.86 TSHR (0.43) TSHRHSD17B10DGKAALDH1A1TP53
Cyclopropane SCHEMBL98406 0.86 TSHR (0.43) TSHRHSD17B10DGKAALDH1A1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117456-A1 LCE-BASED ARTIFICIAL MUSCLE FIBER AND PREPARATION METHOD AND USE THEREOF NANJING DRUM TOWER HOSPITAL (CN) 2026-04-30 US claimed
US-20260021142-A1 HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION GEORGIA TECH RES INST (US) 2026-01-22 US claimed
EP-4642651-A1 PHOSPHINE OXIDE-BASED PHOTOINITIATORS ARKEMA France (FR) 2025-11-05 EP claimed
EP-4558545-A1 HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION Georgia Tech Research Corporation (US) 2025-05-28 EP claimed
WO-2024141190-A1 PHOSPHINE OXIDE-BASED PHOTOINITIATORS ARKEMA FRANCE (FR) 2024-07-04 WO claimed
US-20240216271-A1 HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF GEORGIA TECH RESEARCH CORPORATION 2024-07-04 US claimed
EP-4351671-A2 HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF Georgia Tech Research Corporation (US) 2024-04-17 EP claimed
WO-2024020439-A1 HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION GEORGIA TECH RESEARCH CORPORATION (US) 2024-01-25 WO claimed
WO-2022251468-A2 HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2022-12-01 WO claimed
US-10179831-B2 Amine-catalyzed thiol-curing of epoxide resins tooz technologies GmbH (DE) 2019-01-15 US claimed
US-20170174823-A1 AMINE-CATALYZED THIOL-CURING OF EPOXIDE RESINS tooz technologies GmbH (DE) 2017-06-22 US claimed
US-20140296431-A1 METHOD FOR PRODUCING POLYURETHANE LENS HOYA CORPORATION (JP) 2014-10-02 US claimed
EP-2752684-A1 METHOD FOR PRODUCING POLYURETHANE LENS Hoya Corporation (JP) 2014-07-09 EP claimed
EP-1131483-B1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES CIBA SC HOLDING AG (CH) 2003-11-05 EP claimed
US-6599326-B1 Composition having reduced loss of brightness and enhanced resistance to yellowing which comprises chemical paper which may still contain traces of lignin and N,N-dialkylhydroxylamine or derivative or salt thereof CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-29 US claimed
US-20020174964-A1 Inhibition of pulp and paper yellowing using hydroxylamines and other coadditives SELTZER RAYMOND (US) 2002-11-28 US claimed
US-20020088574-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES CIBA SPECIALTY CHEMICALS CORP. 2002-07-11 US claimed
EP-1131483-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES Ciba SC Holding AG (CH) 2001-09-12 EP claimed
WO-2000024963-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-04 WO claimed
US-4412897-A POLYVINYL HALIDES, HYDROQUINONE, ORGANOTIN OR ORGANOANTIMONY COMPOUND, MERCAPTAN ATO CHIMIE (FR) 1983-11-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216271-A1 HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF MMP1, MMP2, IDUA TSHR 3551/4885HSD17B10 639/4885DGKA 382/4885
US-20260021142-A1 HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION KDM8, PTMS, USP2 TSHR 1371/4885HSD17B10 802/4885DGKA 4078/4885
US-20260117456-A1 LCE-BASED ARTIFICIAL MUSCLE FIBER AND PREPARATION METHOD AND USE THEREOF MYLK2, MYH10, TNNC1 TSHR 745/4885HSD17B10 3095/4885DGKA 3391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.